The European Medicines Agency (EMA) has announced changes in leadership for both its IT division and its Committee for Advanced Therapies (CAT).
Dina Tsiambaou (pictured) joins the Agency, which regulates medicines in the EU, as head of the IT development department. She was previously a senior manager in IT at management consultancy Accenture.
In this role she gained experience working in a number of regions, including China, Mauritius, Thailand, Singapore, Turkey, the US, Germany and Ireland.
The EMA’s other new appointment was that of Dr Paula Salmikangas as chair of the CAT, the EMA committee responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products.
She was previously vice-chair of the committee and succeeds Christian Schneider, who had chaired the CAT since its creation in 2009.
In addition to her EMA role, Dr Salmikangas is a senior research at the Finnish Medicines Agency.